While higher doses (particularly 54 mg) showed some increase in gastrointestinal-related events, these remained mild to moderate in severity and did not result in treatment discontinuation
Clinical Evidence : Emerging clinical research supports NAD+ therapy for improving mitochondrial function, energy levels, and cognitive performance
Indeed, this activity of the peptide was the first to be demonstrated, and it remained one of the most adequately described
Other Ingredients:Rice Powder, Microcrystalline Cellulose, Vegetable Capsule (Hypromellose)
Molecular Metabolism , 49
2.3.2 Plasma pharmacokinetic parameters of BPC157 in rats evaluated based on total radioactivity After a single IM injection of 100 g/300 Ci/kg [3H]BPC157 in jugular vein cannulated (JVC) rats, the total radioactivity concentrations in the whole blood and plasma were similar between males and females